Price Alert

Royalty Pharma (RPRX)

NASDAQ: RPRX · Real-Time Price · USD

36.34

-0.16 (-0.44%)

At close: Aug 15, 2025, 3:59 PM

36.08

-0.72%

After-hours: Aug 15, 2025, 07:21 PM EDT

Royalty Pharma Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Revenue	578.66M	568.25M	594M	564.69M	537.27M	567.98M	596M	536.31M	538.2M	683.97M	565.75M	573.46M	535.96M	562.05M	575.7M	585.77M	554.96M	573.03M
Cost of Revenue	n/a	n/a	n/a	1.65M	6M	583.6M	76.51M	277.14M	241.23M	118.8M	5.67M	305.06M	105.71M	5.67M	266.5M	5.8M	5.73M	5.67M
Gross Profit	n/a	568.25M	594M	563.04M	531.27M	-15.62M	519.49M	259.18M	296.97M	565.17M	560.08M	268.4M	430.24M	556.38M	309.19M	579.98M	549.23M	567.36M
Operating Income	209.8M	534.18M	362M	735.07M	269.63M	-73.77M	613M	151.44M	248.84M	478.97M	95.34M	192.21M	227.64M	219.72M	153.42M	303.05M	744.95M	229.3M
Interest Income	8.33M	11.29M	9.04M	17.51M	13.38M	7.42M	6.5M	23.44M	25.65M	16.7M	43.85M	14.03M	10.92M	9.53M	10.64M	12.26M	14.04M	16.6M
Pretax Income	90.64M	433.43M	334M	806.36M	194.38M	-4.27M	718M	122.08M	351.34M	509.09M	-610.03M	220.41M	491.6M	128.08M	53.67M	221.8M	806.75M	158.98M
Net Income	30.18M	238.35M	208M	543.99M	102M	4.78M	494.34M	72.11M	227.63M	340.75M	-610.17M	217.83M	304.5M	-39.87M	7.9M	101.93M	440.78M	69.12M
Selling & General & Admin	272.3M	110.7M	68M	56.72M	54.71M	57.65M	59M	57.23M	47.63M	85.69M	73.23M	50.69M	51.84M	51.54M	46.16M	48.59M	44.92M	43.16M
Research & Development	300.5M	50.5M	1M	500K	500K	500K	1M	50.5M	500K	500K	50.5M	25.5M	606K	100.5M	103.82M	90.5M	3.12M	2.64M
Other Expenses	-203.94M	-127.14M	163M	-227.6M	-212.43M	-583.6M	77M	-1.71M	1.09M	118.8M	308.85M	305.06M	105.71M	190.29M	-4.82M	-793K	-107K	43K
Operating Expenses	368.87M	34.06M	232M	-170.38M	267.64M	641.75M	-17M	384.87M	289.36M	205M	432.58M	381.25M	158.16M	342.33M	422.28M	282.72M	-189.99M	343.73M
Interest Expense	68.67M	65.26M	65.76M	66.51M	49.01M	44.23M	47M	46.03M	46.95M	46.95M	46.95M	46.98M	46.97M	47.06M	46.97M	44.33M	37.43M	37.41M
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	-185K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	368.87M	34.06M	232M	-170.38M	267.64M	641.75M	-17M	384.87M	289.36M	205M	432.58M	381.25M	158.16M	342.33M	422.28M	282.72M	-189.99M	343.73M
Income Tax Expense	60.46M	n/a	126M	n/a	n/a	n/a	223M	n/a	n/a	n/a	139K	2.58M	187.09M	167.96M	n/a	n/a	n/a	n/a
Shares Outstanding (Basic)	423.51M	433.44M	447.63M	447.63M	451.02M	448.62M	446.57M	448.44M	450.4M	445.61M	443.17M	607.23M	607.21M	607.2M	428.23M	428.23M	409.34M	389.76M
Shares Outstanding (Diluted)	562.3M	578.1M	592.73M	592.73M	596.91M	597.48M	446.57M	601.14M	605.86M	607.25M	443.17M	607.23M	607.21M	607.2M	607.17M	607.17M	607.16M	607.15M
EPS (Basic)	0.07	0.55	0.46	1.61	0.23	0.01	1.11	0.16	0.51	0.76	-1.38	0.36	0.50	-0.07	0.02	0.24	1.08	0.18
EPS (Diluted)	0.07	0.41	0.35	1.21	0.23	0.01	1.11	0.16	0.50	0.76	-1.38	0.36	0.50	-0.07	0.01	0.24	1.08	0.11
EBITDA	159.3M	498.69M	362M	872.86M	560M	39.96M	673.87M	168.11M	398.29M	556.04M	-606.04M	267.39M	538.56M	225.39M	83.44M	308.85M	750.68M	234.97M
EBIT	159.3M	498.69M	400M	872.86M	243.39M	39.96M	764.84M	168.11M	398.29M	556.04M	-563M	192.21M	377.79M	219.72M	100M	303.05M	744.95M	229.3M
Depreciation & Amortization	n/a	n/a	n/a	n/a	560M	729.77M	1.42M	1.42M	1.42M	1.42M	73.67M	-15K	160.77M	5.67M	6M	5.8M	5.73M	5.67M